Monitor next quarterly report for how proceeds are deployed, particularly whether debt repayment or capex dominates. The timing of this raise shortly after an earnings miss and guidance cut suggests potential cash flow pressure; watch for any further debt issuances or credit rating actions.
How the stock moved after the report
NEUTRAL VIEWSTOCK BELOW ENTRY AT T+1- T+0 · Nov 13 $65.03entry
- T+1 · 19h ago −2.37%α −0.46% · $63.49
- T+5 · in 3d Pending
- T+20 · in 27d Pending
- T+60 · in 3mo Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Eastman Chemical issued $300 million of 5.500% senior unsecured notes due 2030, completing a debt capital raise that was preceded by a preliminary prospectus supplement filed 10 days earlier. Net proceeds of approximately $297.7 million will be used for general corporate purposes including working capital, capex, and debt repayment. The offering follows the company's Q3 2026 earnings miss and lowered full-year guidance reported earlier this month, suggesting the debt raise may address cash needs after weaker results.
Key Financial Metrics
Key Facts
- Eastman Chemical issued $300,000,000 aggregate principal amount of 5.500% Notes due 2030
- Net proceeds expected to be approximately $297.7 million after underwriting discounts and estimated expenses
- Notes mature February 25, 2030 with semi-annual interest payments at 5.500%
- Underwriters purchased notes at 99.534% of principal; price to public was 99.884%
- Proceeds intended for general corporate purposes including working capital, capex, debt repayment, and strategic initiatives
- Offering follows Q3 2026 earnings miss (adjusted EPS $1.84 missed consensus by 4.2%) and lowered full-year guidance reported 10 days prior
- Two 424B5 filings preceded this 8-K: a preliminary prospectus supplement (Nov 2) and a final prospectus supplement (Nov 4) for the same notes
Financial Impact
$300 million debt issuance with net proceeds of ~$297.7 million; 5.500% coupon rate
Risk Factors
- Increased leverage from $300M additional debt
- 5.500% coupon adds ~$16.5M annual interest expense
- Debt raise shortly after earnings miss may signal cash needs
Investment Themes
Documents Analyzed
This report is based on 7 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001193125-26-458417 |
| Document: emn-ex4_2.htm | 0001193125-26-458417 |
| Document: emn-20261112.htm | 0001193125-26-458417 |
| Document: emn-ex5_1.htm | 0001193125-26-458417 |
| Document: 0001193125-26-458417-index-headers.html | 0001193125-26-458417 |
| Document: 0001193125-26-458417-index.html | 0001193125-26-458417 |
| Document: 0001193125-26-458417.txt | 0001193125-26-458417 |
Track record
7 reports on EMN
The track record builds as more bullish or bearish reports settle.
Filters
- Nov 12, 20264d ago 8-K Neutral 3/10 Viewing Entry $65.03 Now $63.49 −2.37% settles Nov 20
- Nov 3, 202613d ago 424B5 Neutral 3/10 Entry $67.61 to $66.51 Now $63.49 −6.09% ▼ −1.63% −0.71% vs SPY
- Nov 2, 202614d ago 424B5 Neutral 3/10 Entry $66.78 to $65.39 Now $63.49 −4.93% ▼ −2.08% −2.16% vs SPY
- Oct 29, 202618d ago 8-K Bearish 5/10 Entry $66.53 to $64.41 Now $63.49 +4.57% ▲ +3.19% +0.48% vs SPY
- Oct 21, 202626d ago Institutional Cluster Neutral 3/10 Entry $65.31 to $67.93 Now $63.49 −2.79% ▲ +4.01% +3.30% vs SPY
- Oct 20, 202627d ago 8-K Neutral 2/10 Entry $63.50 to $66.12 Now $63.49 −0.02% ▲ +4.13% +4.57% vs SPY
- Mar 24, 202633w ago DEFA14A Neutral 3/10 Entry $71.40 to $75.81 Now $63.49 −11.08% ▲ +6.18% +6.42% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers